Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Germ Cell and Embryonal
Description
Neoplasms composed of primordial GERM CELLS of embryonic GONADS or of elements of the germ layers of the EMBRYO, MAMMALIAN. The concept does not refer to neoplasms located in the gonads or present in an embryo or FETUS. MeSH
Hierarchy View
Subtype Terms (9)
Carcinoma, Embryonal
7 approved drugs
Chordoma
33 drugs (19 approved, 14 experimental)
Germinoma
20 drugs (18 approved, 2 experimental)
Teratocarcinoma
1 approved drug
Teratoma
20 drugs (16 approved, 4 experimental)
Trophoblastic Neoplasms
1 approved drug
Phase 2 Indicated Drugs (59)
Phase 1 Indicated Drugs (41)
Other Experimental Indicated Drugs (5)
Organization Involved with Phase 4 Indications (6)
Organization Involved with Phase 3 Indications (42)
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Blueprint Medicines Corporation
Cancer and Leukemia Group B (CALGB)
Eastern Cooperative Oncology Group
European Organisation for Research and Treatment of Cancer
Hoosier Cancer Research Network
Organization Involved with Phase 2 Indications (58)
British Columbia Cancer Agency
Canadian Urologic Oncology Group
Cancer Treatment Centers of America
German Testicular Cancer Study Group
Istituto Nazionale per lo Studio e la Cura dei Tumori
Ligue contre le cancer, France
Moorgreen Hospital, Southampton
National Cancer Institute, France
National Cancer Institute, Slovakia
National Institute of Neurological Disorders and Stroke (NINDS)
Organization Involved with Phase 1 Indications (11)
Organization Involved with Other Experimental Indications (4)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
